Analyst firms · Morgan Stanley · MAC
Morgan Stanley MAC price target and rating history
Macerich Company (MAC) · Real Estate
Morgan Stanley rates Macerich Company (MAC) Equal-Weight with a $20 price target, as of its latest action on Jan 15, 2025. It has published 4 rating actions on MAC since August 2021, including 1 upgrade and 0 downgrades. Across 9 firms with a MAC price target in the last 12 months, the median target is $26.
- Current rating
- Equal-Weight
- Price target
- $20
- Median target, all firms
- $26
- Actions on MAC
- 4
Morgan Stanley price target on MAC
Every Morgan Stanley rating on MAC
- Jan 15, 2025
- Dec 16, 2022
- Mar 7, 2022
- Aug 19, 2021
How other firms rate MAC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BNP Paribas Exane | Outperform | $28 | Oct 9, 2026 |
| Truist Securities | Buy | $26 | Oct 2, 2026 |
| Evercore ISI | Outperform | $26 | Sep 21, 2026 |
| Piper Sandler | Overweight | $30 | Aug 27, 2026 |
| Compass Point | Neutral | $26 | Jun 26, 2026 |
| Citigroup | Buy | $28 | Jun 24, 2026 |
| Deutsche Bank | Buy | $27 | Jun 2, 2026 |
| Scotiabank | Sector Outperform | $22 | Mar 30, 2026 |
| KeyBanc Capital Markets | Overweight | $25 | Feb 23, 2026 |
Questions about Morgan Stanley and MAC
- What is Morgan Stanley's price target for MAC?
- Morgan Stanley's latest stated price target for Macerich Company (MAC) is $20, from its action on Jan 15, 2025.
- What is Morgan Stanley's rating on MAC?
- Morgan Stanley rates MAC Equal-Weight, a neutral rating, as of Jan 15, 2025.
- When did Morgan Stanley last change its view on MAC?
- On Jan 15, 2025, Morgan Stanley upgrades to Equal-Weight from Underweight, price target $20.
- How does Morgan Stanley's MAC target compare with other analysts?
- Across 9 firms with a MAC price target in the last 12 months, the median target is $26.
More MAC rating histories
All Morgan Stanley ratingsMAC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.